Innio And 2 Additional Stocks Estimated To Be Priced Below Their Intrinsic Value

Over the last 7 days, the United States market has risen by 4.9%, contributing to a substantial 21% increase over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying stocks that are priced below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Tutor Perini (TPC)	$85.71	$161.41	46.9%
Rayonier (RYN)	$21.93	$43.15	49.2%
Natera (NTRA)	$275.19	$537.74	48.8%
Inter & Co (INTR)	$5.70	$11.26	49.4%
Huntington Bancshares (HBAN)	$17.56	$33.02	46.8%
Hims & Hers Health (HIMS)	$32.16	$61.59	47.8%
HBT Financial (HBT)	$36.13	$69.21	47.8%
HawkEye 360 (HAWK)	$24.30	$48.07	49.4%
Goosehead Insurance (GSHD)	$68.56	$134.00	48.8%
Commvault Systems (CVLT)	$132.10	$249.57	47.1%

Click here to see the full list of 142 stocks from our Undervalued US Stocks Based On Cash Flows screener.

Here we highlight a subset of our preferred stocks from the screener.

Innio (INIO)

Overview: Innio N.V., with a market cap of $18.68 billion, operates through its subsidiaries to provide power generation equipment and services under the Jenbacher and Waukesha brands.

Operations: The company's revenue segments consist of $1.40 billion from services and $1.69 billion from equipment sales.

Estimated Discount To Fair Value: 25.4%

Innio is trading at US$27.35, below its estimated future cash flow value of US$36.66, suggesting it may be undervalued based on cash flows. Despite a recent net loss and volatile share price, Innio's revenue grew by 29% over the past year and is forecast to grow at 20.4% annually, surpassing the market rate. A significant order for gas engine capacity enhances multi-year revenue visibility amid expectations of substantial earnings growth over the next three years.

• Our growth report here indicates Innio may be poised for an improving outlook.
• Click here and access our complete balance sheet health report to understand the dynamics of Innio.

Hims & Hers Health (HIMS)

Overview: Hims & Hers Health, Inc. is a consumer-focused health and wellness platform that links consumers with licensed healthcare professionals across several countries, with a market cap of $7.13 billion.

Operations: The company's revenue is primarily generated through online retailers, amounting to $2.37 billion.

Estimated Discount To Fair Value: 47.8%

Hims & Hers Health is trading at US$32.16, well below its estimated future cash flow value of US$61.59, and is considered undervalued based on cash flows. Despite recent legal challenges from the FTC and executive changes, the company anticipates high revenue growth of 23.7% annually, outperforming the market's rate. It is forecasted to become profitable within three years with strong return on equity projections, although share price volatility remains a concern.

• According our earnings growth report, there's an indication that Hims & Hers Health might be ready to expand.
• Unlock comprehensive insights into our analysis of Hims & Hers Health stock in this financial health report.

Waters (WAT)

Overview: Waters Corporation offers analytical workflow solutions across Asia, the Americas, and Europe with a market cap of approximately $36.79 billion.

Operations: Revenue segments for Waters include $2.68 billion from Waters and $1.02 billion from TA Instruments.

Estimated Discount To Fair Value: 18.2%

Waters Corporation is trading at US$396.08, below its estimated future cash flow value of US$484.35, indicating potential undervaluation based on cash flows. Despite recent net losses and lower profit margins compared to last year, the company forecasts significant earnings growth of 33.1% annually over the next three years, surpassing the broader U.S. market's growth rate. However, shareholders have faced substantial dilution recently, and return on equity is expected to remain low at 9.1%.

• Upon reviewing our latest growth report, Waters' projected financial performance appears quite optimistic.
• Click to explore a detailed breakdown of our findings in Waters' balance sheet health report.

Key Takeaways

• Take a closer look at our Undervalued US Stocks Based On Cash Flows list of 142 companies by clicking here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com